Silvercrest Asset Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
1,024,091
+363,150
+55% +$10.2M 0.15% 192
2026
Q1
$24.2M Buy
660,941
+75,999
+13% +$3M 0.17% 158
2025
Q4
$26.7M Sell
584,942
-171,059
-23% -$7.62M 0.18% 155
2025
Q3
$32M Sell
756,001
-779
-0.1% -$29.4K 0.21% 138
2025
Q2
$23.5M Buy
756,780
+275,539
+57% +$7.46M 0.16% 180
2025
Q1
$11.8M Buy
+481,241
New +$13.4M 0.08% 274

Other funds holding AORT

Silvercrest Asset Management's AORT Position: Q2 2026 in Review

Silvercrest Asset Management increased its Artivion (AORT) stake by 55% in Q2 2026, buying an estimated $10.2M and bringing the position to 1,024,091 shares worth $23M. The position accounts for 0.15% of the portfolio, ranked #192.

Silvercrest Asset Management first reported a position in AORT in Q1 2025 and has held it in 6 quarters since. The position peaked at $32M in Q3 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Silvercrest Asset Management held 1,024,091 shares of Artivion worth $23M as of Q2 2026.
  • Silvercrest Asset Management bought 363,150 Artivion shares in Q2 2026, an estimated $10.2M.
  • Artivion made up 0.15% of Silvercrest Asset Management's portfolio in Q2 2026, its #192 holding.
  • Silvercrest Asset Management first reported a position in Artivion in Q1 2025 and has held it in 6 quarters since.
  • Silvercrest Asset Management's Artivion position peaked at $32M in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.